Fecal incontinence in men: Causes and clinical and manometric features

Table 4 Response to treatment n (%)

	No follow-up	Follow-up	Response to treatment
				Wexner score after treatment
				0-1 WS	2- 5 WS	6-9 WS	≥10 WS
Total (n = 764)	145 (19.0)	619 (81.0)		257 (41.5)	241 (38.9)	92 (14.8)	29 (4.7)
Men (n = 119)	36 (30.3)	83 (69.7)	Treatments:	28 (33.7)	39 (46.9)	10 (12.8)	6 (7.2)
n = 50	21 (42.0)	29 (58.0)	Chronic diarrhea1	4 (13.8)	22 (75.9)	2 (6.9)	1 (3.4)
n = 20	8 (40.0)	12 (60.0)	Constipation2	4 (33.3)	6 (50.0)	2 (16.6)	0 (0.0)
n = 12	5 (41.7)	7 (58.3)	Incomplete evacuation3	2 (28.6)	4 (57.1)	1 (14.3)	0 (0.0)
n = 25	0 (0.0)	25 (100.0)	Soiling4	18 (72.0)	6 (24.0)	1 (4.0)	0 (0.0)
n = 12	2 (16.7)	10 (83.3)	Others5	0 (00.0)	1 (10.0)	4 (40.0)	5 (50.0)
Women (n = 645)	109 (16.9)	536 (83.1)	Treatments:	229 (42.7)	202 (37.7)	82 (15.3)	23 (4.3)
n = 289	51 (17.6)	238 (82.3)	Chronic diarrhea1	129 (54.2)	88 (37.0)	21 (8.8)	0 (0.0)
n = 118	28 (23.7)	90 (76.3)	Constipation2	48 (53.3)	35 (38.9)	7 (7.8)	0 (0.0)
n = 74	18 (24.3)	56 (75.7)	Incomplete evacuation3	18 (32.1)	34 (60.7)	4 (7.1)	0 (0.0)
n = 32	2 (6.3)	30 (93.7)	Soiling4	22 (73.3)	6 (23.3)	2 (3.3)	0 (0.0)
n = 132	10 (7.6)	122 (92.4)	Others5	12 (9.8)	39 (31.9)	48 (39.3)	23 (18.8)
χ2 (P) (men vs women)	4.98 (< 0.05)	4.98 (< 0.05)		1.72 (NS)	1.73 (NS)	0.26 (NS)	0.78 (NS)

¹Patients with chronic diarrhea were treated in a stepwise approach according to the response: (1) dietary modification and loperamide; (2) resin-cholysteramine or codeine phosphate; (3) otilonium bromide; and (4) amitriptyline;

²Patients with constipation were treated with: (1) a fiber-rich diet and a bulking agent; (2) osmotic laxative; and (3) glycerol suppositories or enemas;

³Patients with incomplete evacuation were treated with bulking agents with or without glycerol suppositories or enema;

⁴Patients with soiling started with fiber-rich diet and bulking agents; glycerol suppositories or enema;

⁵Patients with inflammatory bowel disease, prolapses, neurological diseases required special treatment including specific therapy, surgery, anal plugs, sacral nerve electrostimulation, or a combination of several measures. NS: Not significant; WS: Wexner score.